Symptom experience after solid organ transplantation

Journal of Psychosomatic Research

Volumn 66, Issue 2, 2009, Pages 101-110

  Kugler, Christiane ^a   Geyer, Siegfried ^a   Gottlieb, Jens ^a   Simon, Andre ^a   Haverich, Axel ^a   Dracup, Kathleen ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adherence; Organ transplantation; Quality of life; Symptom experience

Indexed keywords

HEALTH STATUS; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE;

EID: 58149494128     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2008.07.017     Document Type: Article

References (55)

1. Taylor D.O., Edwards L.B., Boucek M.M., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report-2007. J Heart Lung Transplant 26 (2007) 769-781
2. Trulock E.P., Christie J.D., Edwards L.B., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplant report-2007. J Heart Lung Transplant 26 (2007) 782-795
3. Butler J., McCoin N.S., Feurer I.D., et al. Modelling the effects of functional performance and post-transplant comorbidities and health-related quality of life after heart transplantation. J Heart Lung Transplant 22 (2003) 1149-1156
4. Karam V.H., Gasquet I., Delvart V., et al. Quality of life in adult survivors beyond 10 years after liver, kidney, and heart transplantation. Transplantation 76 (2003) 1699-1704
5. Vermeulen K.M., Ouwens J.P., van der Bij W., et al. Long-term quality of life in patients surviving at least 55 months after lung transplantation. Gen Hosp Psychiatry 25 (2003) 95-102
6. Barr M.L., Schenkel F.A., Van Kirk A., et al. Determinants of quality of life changes among long-term cardiac transplant survivors: results from longitudinal data. J Heart Lung Transplant 22 (2003) 1157-1167
7. Kugler C., Fischer S., Gottlieb J., et al. Health-related quality of life in two hundred-eighty lung transplant recipients. J Heart Lung Transplant 24 (2005) 2262-2268
8. Rutherford R.M., Fisher A.J., Hilton C., et al. Functional status and quality of life in patients surviving 10 years after lung transplantation. Am J Transplant 5 (2005) 1099-1104
9. Pascual M., Theruvath T., Kawai T., Tolkoff-Rubin N., and Cosimi B. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 346 (2002) 580-590
10. Dobbels F., De Geest S., Van Cleemput J., et al. Effect of late medication non-compliance on outcome after heart transplantation: a 5-year follow-up. J Heart Lung Transplant 23 (2004) 1245-1251
11. Vlaminck H., Maes B., Evers G., et al. Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients. Am J Transplant 4 (2004) 1509-1513
12. De Geest S., Borgersmans L., Gemoets H., Abraham I., Vlaminck H., Evers G., et al. Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation 59 (1995) 340-347
13. Hathaway D.K., Winsett R., Prendergast M., and Subaiya I. The first report from the patient outcomes registry for transplant effects on life (PORTEL): differences in side-effects and quality of life by organ type, time since transplant and immunosuppressive regimens. Clin Transplant 17 (2003) 183-194
14. Kugler C., Fischer S., Gottlieb J., et al. Symptom experiences after lung transplantation: influences on adherence and quality of life. Clin Transplant 21 (2007) 590-596
15. Winsett R.P., Stratta R.J., Alloway R., Wicks M.N., and Hathaway D.K. Immunosuppressant side effect profile does not differ between organ transplant types. Clin Transplant 15 (2001) 46-50
16. Winsett RP, Arheart K, Stratta RJ, et al. Evaluation of an immunosuppressant side effect instrument. Progr Transplant 2004;14:210-216; 240-247.
17. Rhodes V.A., and Watson P.M. Symptom distress, the concept: past and present. Semin Oncol 3 (1987) 242-247
18. Lenz E.R., Pugh L.C., Milligan R.A., Gift A., and Suppe F. The middle-range theory of unpleasant symptoms: an update. Adv Nurs Sci 19 (1997) 14-27
19. Dodd M., Janson S., Facione N., et al. Advancing the science of symptom management. J Adv Nurs 33 (2001) 668-676
20. DeVito Dabbs A., Hoffman L.A., Swigart V., et al. Striving for normalcy: symptoms and the threat of rejection after lung transplantation. Soc Sci Med 59 (2004) 1473-1484
21. Lough M.E., Lindsey A.M., Shinn J.A., and Stotts N.A. Impact of symptom frequency and symptom distress on self-reported quality of life in heart transplant recipients. Heart Lung 16 (1987) 193-200
22. Jalowiec A., Grady K.L., White-Williams C., et al. Symptom distress three months after heart transplantation. J Heart Lung Transplant 16 (1997) 604-614
23. Moons P., De Geest S., Abraham I., et al. Symptom experience associated with maintenance immunosuppression after heart transplantation: patient's appraisal of side effects. Heart Lung 27 (1998) 315-325
24. Moons P., Vanrenterghem Y., Van Hooff J.P., et al. Health-related quality of life and symptom experience in tacrolimus-based regimens after renal transplantation: a multicentre study. Transpl Int 9 (2003) 653-664
25. Peters T.G., Spinola K.N., West J.C., Aeder M.I., Danovitch G.M., and First M.R. Differences in patient and transplant professional perceptions of immunosuppression-induced cosmetic side effects. Transplantation 78 (2004) 537-543
26. Moons P., De Geest S., Versteven K., et al. Psychometric properties of the "Modified Transplant Symptom Occurrence and Symptom Distress Scale". J Nurs Meas 9 (2001) 115-134
27. Rosenberger J., Geckova A.M., van Dijk J.P., Roland R., van den Heuvel W., and Groothoff J.W. Factors modifying stress from adverse effects of immunosuppressive medication in kidney transplant recipients. Clin Transplant 19 (2005) 70-76
28. Teixeira de Barros C., and Cabrita J. Self-report of symptom frequency and symptom distress in kidney transplant recipients. Pharmacoepidemiol Drug Saf 8 (1999) 395-403
29. Matas A.J., Halbert R.J., Barr M.L., et al. Life satisfaction and adverse effects in renal transplant recipients: a longitudinal analysis. Clin Transplantation 16 (2002) 113-121
30. Leventhal H., and Cameron L. Behavioral theories and problem of compliance. Patient Educ Couns 10 (1987) 117-138
31. De Bona M., Ponton P., Iemmolo M.R., et al. The impact of liver disease and medical complications on quality of life and psychological distress before and after liver transplantation. J Hepatol 33 (2000) 609-615
32. Galbraith C.A., and Hathaway D.K. Long-term effects of transplantation on quality of life. Transplantation 77 (2004) S84-S87
33. DeVito Dabbs A., Dew M.A., Stilley C.S., et al. Psychosocial vulnerability, physical symptoms and physical impairment after lung and heart-lung transplantation. J Heart Lung Transplant 22 (2003) 1268-1275
34. Chisholm M.A., Mulloy L.L., and DiPiro J.T. Comparing renal transplant patients' adherence to free cyclosporine and free tacrolimus immunosuppressant therapy. Clin Transplant 19 (2005) 77-82
35. De Geest S., Moons P., Dobbels F., et al. Profiles of patients who experienced a late acute rejection due to nonadherence with immunosuppressive therapy. J Cardiovasc Nurs 16 (2001) 1-14
36. Dew M.A., and DiMartini A.F. Psychological disorders and distress after adult cardiothoracic transplantation. J Cardiovasc Nurs 20 5S (2005) 51-66
37. Center for Drug Evaluation and Research (CDER). Patient reported outcome measures: use in medical product development to support labelling claims. 5460 draft (2006), US Department of Health and Human Services, Rockville (Md)
38. DeVito Dabbs A., Yookyung K., Vensak J., Studer S., and Iaccono A. Validation and refinement of the questionnaire for lung transplant patients. Prog Transplant 14 (2004) 338-345
39. Dobbels F., Moons P., Abraham I., et al. Measuring symptom experience of side-effects of immunosuppressive drugs: the modified transplant symptom occurrence and distress scale. Transpl Int 8 (2008) 764-773
40. DeVito Dabbs A., Hoffman L.A., Dauber J.H., et al. Evaluating the reliability and validity of the Questionnaire for Lung Transplant Patients. Progr Transplant 12 (2002) 191-198
41. Hagyvary S. Patient care outcomes related to management of symptoms. Annu Rev Nurs Res 11 (1993) 145-168
42. Mac Naughton K.L., Rodrigue J.R., Cicale M., et al. Health related quality of life and symptom frequency before and after lung transplantation. Clin Transplant 12 (1998) 320-323
43. Dew M.A. Behavioral factors in heart transplantation: quality of life and medical compliance. J Appl Biobehav Res 2 (1994) 28-54
44. Costello A., and Pearson G.J. Transplant Pharmacology. In: Ohler L., and Cupples S. (Eds). Core Curriculum for Transplant Nurses. 1 ed. (2008), Mosby Elsevier, St. Lois (Mo) 89-132
45. Lanuza D.M., McCabe M., Norton-Rosko M., Corliss J.W., and Garrity E. Symptom experiences of lung transplant recipients: comparisons across gender, pre-transplantation diagnosis, and type of transplantation. Heart Lung 28 (1999) 429-437
46. Yao G., Albon E., Adi Y., et al. A systematic review and economic model on the clinical and cost-effectiveness of immunosuppressive therapy for renal transplantation in children. Health Technol Assess 10 (2006) 1-194
47. Reimer J., Franke G.H., Philipp T., and Heemann U. Quality of life in kidney recipients: comparison of tacrolimus and cyclosporine-microemulsion. Clin Transplant 16 (2002) 48-54
48. Fiebiger W., Mitterbauer C., and Oberbauer R. Health-related quality of life outcomes after kidney transplantation. Health Qual Life Outcomes 2 (2004) 1-6
49. Woodroffe R., Yao G.L., Meads C., et al. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study. Health Technol Assess 9 (2005) 1-194
50. Franke G.H., Trampenau C., Reimer J., et al. Switching from cyclosporine to tacrolimus leads to improved disease-specific quality of life in patients after kidney transplantation. Transplant Proc 38 (2006) 1293-1294
51. Cleemput I., Kesteloot K., Vanrenthergem Y., and De Geest S. The economic implications of non-adherence after renal transplantation. Pharmacoeconomics 22 (2004) 1217-1234
52. Sketris I., Grobler M., West M., and Gerus S. Factors affecting compliance with cyclosporine in adult renal transplant recipients. Transplant Proc 26 (1994) 2538-2541
53. Chisholm M.A. Identification of medication-adherence barriers and strategies to increase adherence in recipients of renal transplants. Manag Care Interface 17 (2004) 44-48
54. Hilbrands L.B., Hoitsma A.J., and Koene R.A. Medication compliance after renal transplantation. Transplantation 60 (1995) 914-920
55. Kugler C., Fischer S., Simon A., Haverich A., and Strueber M. Compliance after solid organ transplantation-influenced by quality of life and the health-care-provider-patient-relationship. Dtsch Med Wochenschr 132 (2007) 1-5